Encompass Health Corp (EHC)
79.14
+0.52
(+0.66%)
USD |
NYSE |
Apr 19, 16:00
79.14
0.00 (0.00%)
After-Hours: 20:00
Encompass Health Enterprise Value: 11.17B for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 18, 2024 | 11.17B |
| April 17, 2024 | 11.27B |
| April 16, 2024 | 11.30B |
| April 15, 2024 | 11.38B |
| April 12, 2024 | 11.35B |
| April 11, 2024 | 11.47B |
| April 10, 2024 | 11.46B |
| April 09, 2024 | 11.50B |
| April 08, 2024 | 11.54B |
| April 05, 2024 | 11.64B |
| April 04, 2024 | 11.40B |
| April 03, 2024 | 11.52B |
| April 02, 2024 | 11.50B |
| April 01, 2024 | 11.63B |
| March 28, 2024 | 11.56B |
| March 27, 2024 | 11.08B |
| March 26, 2024 | 10.98B |
| March 25, 2024 | 10.92B |
| March 22, 2024 | 10.95B |
| March 21, 2024 | 11.03B |
| March 20, 2024 | 10.97B |
| March 19, 2024 | 11.03B |
| March 18, 2024 | 10.90B |
| March 15, 2024 | 10.78B |
| March 14, 2024 | 10.81B |
| Date | Value |
|---|---|
| March 13, 2024 | 10.92B |
| March 12, 2024 | 11.00B |
| March 11, 2024 | 10.88B |
| March 08, 2024 | 10.95B |
| March 07, 2024 | 11.04B |
| March 06, 2024 | 10.96B |
| March 05, 2024 | 10.78B |
| March 04, 2024 | 10.79B |
| March 01, 2024 | 10.72B |
| February 29, 2024 | 10.74B |
| February 28, 2024 | 10.78B |
| February 27, 2024 | 10.84B |
| February 26, 2024 | 10.84B |
| February 23, 2024 | 10.83B |
| February 22, 2024 | 10.72B |
| February 21, 2024 | 10.76B |
| February 20, 2024 | 10.70B |
| February 16, 2024 | 10.66B |
| February 15, 2024 | 10.68B |
| February 14, 2024 | 10.64B |
| February 13, 2024 | 10.62B |
| February 12, 2024 | 10.67B |
| February 09, 2024 | 10.60B |
| February 08, 2024 | 10.66B |
| February 07, 2024 | 10.59B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
7.467B
Minimum
Mar 23 2020
11.64B
Maximum
Apr 05 2024
9.357B
Average
9.430B
Median
Enterprise Value Benchmarks
| DaVita Inc | 20.70B |
| Pediatrix Medical Group Inc | 1.187B |
| US Physical Therapy Inc | 1.639B |
| The Oncology Institute Inc | 95.38M |
| American Oncology Network Inc | 297.10M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 87.60M |
| Revenue (Quarterly) | 1.247B |
| Total Expenses (Quarterly) | 1.057B |
| EPS Diluted (Quarterly) | 0.86 |
| Gross Profit Margin (Quarterly) | 95.30% |
| Profit Margin (Quarterly) | 7.03% |
| Earnings Yield | 4.38% |
| Operating Earnings Yield | 9.13% |
| Normalized Earnings Yield | 4.524 |